Nutra Pharma Corp. (NPHC)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Nutra Pharma Revenue
Nutra Pharma had revenue of $98.70K in the quarter ending September 30, 2025, a decrease of -9.83%. This brings the company's revenue in the last twelve months to $452.77K, up 11.59% year-over-year. In the year 2024, Nutra Pharma had annual revenue of $392.15K, down -34.08%.
Revenue (ttm)
452.77K
Revenue Growth
+11.59%
P/S Ratio
4.74
Revenue / Employee
75.46K
Employees
6
Market Cap
2.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 392.15K | -202.73K | -34.08% |
| Dec 31, 2023 | 594.88K | 156.61K | 35.73% |
| Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
| Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
| Dec 31, 2020 | 51.90K | -52.50K | -50.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sibannac | 434.00 |
| CannaPharmaRX | 1.36M |
| CBD Life Sciences | 178.45K |
| Nascent Pharma Holdings | 1.03M |
| Medical Marijuana | 58.98M |
| Bespoke Extracts | 1.42M |
| Panacea Life Sciences Holdings | 2.76M |
| Procyon | 4.98M |